Normalization of Liver Fat Following Treatment with Efruxifermin & Relationship with Histologic & Metabolic Improvements

Time: 4:00 pm
day: Day Two


• Learning about the six-fold higher probability of NASH resolution with liver fat normalization
• Investigating the correlation between change in liver fat and decrease in markers of liver stress, injury, and restoration of metabolic health
• Analyzing the consistent improvements in fibrosis as assessed by serum markers, imaging, and histology in NASH patients with F1-F4 fibrosis